The Institute of Cancer Research, London
WEBSearch is our supporter newsletter. Subscribe to read our latest news and research, as well as interviews with our world-leading scientists and clinicians. The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations, with an outstanding record of achievement.
About Us - The Institute of Cancer Research, London
WEBAs well as being as world-class research institute, the ICR is a higher education institution and a member institution of the University of London. We came second-top in the league table of university research quality, impact and environment compiled from the most recent Research Excellence Framework (REF 2021).
Our Research - The Institute of Cancer Research, London
WEBThe Institute of Cancer Research, London, has been driving scientific discoveries on cancer and its treatment for more than 100 years. We are internationally renowned for our work into cancer genetics, cancer biology and personalised medicine – and came second of all UK universities in analysis of the 2021 Research Excellence Framework.
PhDs for science graduates - Institute of Cancer Research
WEBPhDs for science graduates. Our competitive PhD programme is designed for the next generation of world-leading scientists who want a career in cancer research. Our PhD students benefit from an above average salary and exceptional research facilities. Our aim is to attract the best minds in the world to join us in our mission - to make the ...
Breast cancer - The Institute of Cancer Research, London
WEBClinical trials. We led trials establishing the effectiveness of the chemotherapy drug carboplatin – discovered at the ICR – in triple-negative breast cancer, and of the targeted drug palbociclib in advanced, metastatic breast cancer.. Recently, results from the OlympiA trial showed that using the targeted drug olaparib to treat some women with early stage breast cancer and mutations in ...
News - The Institute of Cancer Research, London
WEBUntapping the full potential of immunotherapies for more people with cancer 06Jun2023. Immunotherapy works by sparking the body’s own immune system into action against tumours. It has become a first-choice treatment for some types of cancer, and now there are exciting opportunities to unlock its benefits for more patients through research.
About our research - The Institute of Cancer Research, London
WEBAbout our research. Cancer is a highly complex disease with more than 200 types, each caused by a different combination of genetic defects. Even among patients with a single type of cancer, such as breast or lung cancer, the genetic triggers vary from one person to the next. At The Institute of Cancer Research, London, we believe it is ...
World-class research - The Institute of Cancer Research, London
WEBOur world-class research will run from bench to bedside and back again – taking research findings to patients, and learning from the experience in the clinic. We aim to understand cancer better, and improve diagnosis and treatment for patients, by working across four research themes: Unravel the cancer ecosystem. Diagnose better and earlier.
Our strategy - The Institute of Cancer Research, London
WEBNew ICR strategy: Defeating cancer. Our vision: We will transform the lives of cancer patients through world-class research and education, and by growing our impact on society. Video: ICR Chief Executive Kristian Helin gives an overview of our new five-year strategy. Cancer patients are living longer and with a better quality of life.
Our research excellence - The Institute of Cancer Research, London
WEBThe Institute of Cancer Research, London, is the second-ranked academic research centre in the UK - according to the Times Higher Education league table of university research quality and impact compiled from the Research Excellence Framework (REF 2021) - and first for biological sciences. We were also the third-ranked higher education ...
Skip to content